Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E2007 in levodopa-treated Parkinson's disease patients with motor fluctuations
2005-004314-33Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Nov 2005
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of perampanel in Parkinson's disease (PD) (3 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Change in mean total daily OFF time. Started Nov 2005; status: completed.
02
Drugs
perampanel
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2005-004314-33.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-004314-33.